Explore / Peer-reviewed article
Peer-reviewed articleOpen access

UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.

Song-Smith C, Jacobs EiD, Rucker JiD, Saint M, Cooke J, Schlosser MiD

BMJ openMar 14, 2024License: open accessUnited Kingdom, Portugal, Germany8 citationsDOI: 10.1136/bmjopen-2023-083595

Abstract

<h4>Objective</h4>To capture UK medical students' self-reported knowledge and harm assessment of psychedelics and to explore the factors associated with support for changing the legal status of psychedelics to facilitate further clinical research.<h4>Design</h4>Cross-sectional, anonymous online survey of UK medical students using a non-random sampling method.<h4>Setting</h4>UK medical schools recognised by the General Medical Council.<h4>Participants</h4>132 medical students who had spent an average of 3.8 years (SD=1.4; range: 1-6) in medical school.<h4>Results</h4>Most students (83%) reported that they were aware of psychedelic research and only four participants (3%) said that they were not interested in learning more about this type of research. Although medical students' harm assessment of psychedelics closely aligned with that of experts, only 17% of students felt well-educated on psychedelic research. Teachings on psychedelics were only rarely encountered in their curriculum (psilocybin: 14.1 (SD=19.9), scale: 0 (never) to 100 (very often)). Time spent at medical schools was not associated with more knowledge about psychedelics (r=0.12, p=0.129). On average, this sample of medical students showed strong support for changing the legal status of psychedelics to facilitate further research into their potential clinical applications (psilocybin: 80.2 (SD=24.8), scale: 0 (strongly oppose) to 100 (strongly support)). Regression modelling indicated that greater knowledge of psychedelics (p<0.001), lower estimated harm scores (p<0.001), more time spent in medical school (p=0.024) and lower perceived effectiveness of non-pharmacological mental health treatments (p=0.044) were associated with greater support for legal status change.<h4>Conclusions</h4>Our findings reveal a significant interest among UK medical students to learn more about psychedelic research and a strong support for further psychedelic research. Future studies are needed to examine how medical education could be refined to adequately prepare medical students for a changing healthcare landscape in which psychedelic-assisted therapy could soon be implemented in clinical practice.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Psilocybin

Keywords

PsychiatryCross-sectional studiesMedical Education & Training

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.